Elevated eosinophil level predicted long time to next treatment in relapsed or refractory myeloma patients treated with lenalidomide. [electronic resource]
Producer: 20210423Description: 1694-1702 p. digitalISSN:- 2045-7634
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Disease Progression
- Drug Resistance, Neoplasm -- immunology
- Eosinophils -- immunology
- Female
- Follow-Up Studies
- Humans
- Lenalidomide -- administration & dosage
- Leukocyte Count
- Male
- Middle Aged
- Multiple Myeloma -- blood
- Neoplasm Recurrence, Local -- blood
- Predictive Value of Tests
- Prognosis
- Retrospective Studies
- Time Factors
- Time-to-Treatment -- statistics & numerical data
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.